Skip to main content
SpringerLink
Log in

Tumorschmerzen: Opioidwechsel lohnt sich bei Nonrespondern

  • Literatur kompakt
  • Published:
Angewandte Schmerztherapie und Palliativmedizin

Sprechen Patienten mit Tumorschmerzen auf ein oral verabreichtes Opioid nicht gut an, dann lohnt sich der Wechsel auf ein anderes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Quellen

  • Riley J et al. Morphine or Oxycodone for Cancer-Related Pain? A Randomized, Open-Label, Controlled Trial. J Pain Symptom Manage. 2014 Jun 26. [Epub ahead of print]

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Thomas Müller

Authors
  1. Thomas Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, T. Tumorschmerzen: Opioidwechsel lohnt sich bei Nonrespondern. Schmerz und Palliativ 7, 16 (2014). https://doi.org/10.1007/s15223-014-0458-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15223-014-0458-x

Search

Navigation